Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

GenRait

GenRait, Inc. integrates machine learning with web3 for genomic data analysis, aiming to advance personalized medicine.
2021
02-Oct
02-10
Austin, Texas, United States
  • Bioanalytical Devices
  • Bioinformatics
  • Drug Discovery and Development
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Innovation

Industry Problem

Genomic and biomarker data are complex and are not consistently converted into clear, patient-specific diagnostic or treatment decisions.

R&D Focus

Genomics and multi-omics for patient stratification and treatment selection

Innovative Solution

GenRait, Inc. specializes in leveraging genomic data through the integration of machine learning and web3 technologies. With a focus on biotechnology, the company aims to advance the genomic revolution, contributing to the future of personalized medicine and wellbeing.

Investment Funding

Revenue

$1M to $10M

People

Founders

About

GenRait, Inc. specializes in leveraging genomic data through the integration of machine learning and web3 technologies. With a focus on biotechnology, the company aims to advance the genomic revolution, contributing to the future of personalized medicine and wellbeing. GenRait offers data infrastructure and analytics solutions designed to optimize the use of genomic information. The team, comprising 10 employees, collaborates with partners like BioinfoCRO to challenge the status quo in genomics. Through its platform, GenRait facilitates the application of genomic data in life sciences, aiming to solve complex problems such as cold cases with next-generation genomics.

Products

Product

Through its platform, GenRait facilitates the application of genomic data in life sciences, aiming to solve complex problems such as cold cases with next-generation genomics.

Something missing or incorrect on this page? Help us enrich this information